Company Filing History:
Years Active: 2021
Title: The Innovations of Benjamin J. Capoccia
Introduction
Benjamin J. Capoccia is an accomplished inventor based in St. Louis, MO (US). He has made significant contributions to the field of therapeutic antibodies, particularly in the development of anti-SIRPα monoclonal antibodies. His work focuses on innovative solutions for the prevention and treatment of various cancers.
Latest Patents
Capoccia holds a patent for "Therapeutic SIRP-α antibodies." This patent includes anti-SIRPα monoclonal antibodies, which are designed with distinct functional profiles. The patent also covers related compositions and methods for using these antibodies as therapeutics for solid and hematological cancers. Additionally, it provides amino acid sequences of exemplary anti-SIRPα monoclonal antibodies.
Career Highlights
Capoccia is currently associated with Arch Oncology, Inc., where he continues to advance his research in cancer therapeutics. His innovative approach has positioned him as a key figure in the development of new treatment options for patients.
Collaborations
He has collaborated with notable colleagues, including Robyn Puro and Ronald R. Hiebsch, to further enhance the impact of his research and innovations.
Conclusion
Benjamin J. Capoccia's work in the field of therapeutic antibodies exemplifies the potential of innovation in cancer treatment. His contributions are paving the way for new therapeutic strategies that could significantly improve patient outcomes.